A detailed history of Franklin Resources Inc transactions in Sanofi stock. As of the latest transaction made, Franklin Resources Inc holds 3,407,452 shares of SNY stock, worth $165 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,407,452
Previous 8,958,620 61.96%
Holding current value
$165 Million
Previous $517 Million 61.96%
% of portfolio
0.06%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 27, 2024

SELL
$48.54 - $58.53 $269 Million - $325 Million
-5,551,168 Reduced 61.96%
3,407,452 $196 Million
Q3 2024

Nov 12, 2024

BUY
$48.54 - $58.53 $289 Million - $348 Million
5,946,912 Added 197.46%
8,958,620 $517 Million
Q2 2024

Aug 14, 2024

BUY
$45.39 - $50.36 $67 Million - $74.4 Million
1,477,091 Added 96.25%
3,011,708 $146 Million
Q1 2024

May 13, 2024

BUY
$45.75 - $52.48 $64.5 Million - $73.9 Million
1,409,030 Added 1121.96%
1,534,617 $74.6 Million
Q4 2023

Feb 09, 2024

SELL
$43.13 - $54.79 $331,367 - $420,951
-7,683 Reduced 5.76%
125,587 $6.25 Million
Q3 2023

Nov 13, 2023

SELL
$50.95 - $55.2 $2,700 - $2,925
-53 Reduced 0.04%
133,270 $7.15 Million
Q2 2023

Aug 11, 2023

BUY
$50.45 - $57.18 $305,575 - $346,339
6,057 Added 4.76%
133,323 $7.19 Million
Q1 2023

May 12, 2023

BUY
$45.86 - $54.45 $1.15 Million - $1.37 Million
25,106 Added 24.58%
127,266 $6.93 Million
Q4 2022

Feb 10, 2023

BUY
$38.86 - $48.55 $2.08 Million - $2.6 Million
53,477 Added 109.85%
102,160 $4.95 Million
Q3 2022

Nov 14, 2022

SELL
$37.22 - $100.5 $11,314 - $30,552
-304 Reduced 0.62%
48,683 $1.85 Million
Q2 2022

Aug 11, 2022

BUY
$48.99 - $57.46 $43,111 - $50,564
880 Added 1.83%
48,987 $2.45 Million
Q1 2022

May 13, 2022

BUY
$48.48 - $53.65 $251,320 - $278,121
5,184 Added 12.08%
48,107 $2.47 Million
Q4 2021

Feb 11, 2022

SELL
$47.07 - $52.35 $19,863 - $22,091
-422 Reduced 0.97%
42,923 $2.15 Million
Q3 2021

Nov 12, 2021

BUY
$47.89 - $53.12 $155,498 - $172,480
3,247 Added 8.1%
43,345 $2.09 Million
Q2 2021

Aug 13, 2021

SELL
$49.36 - $54.25 $1.83 Million - $2.01 Million
-37,123 Reduced 48.07%
40,098 $2.11 Million
Q1 2021

May 13, 2021

BUY
$45.46 - $50.51 $264,168 - $293,513
5,811 Added 8.14%
77,221 $3.82 Million
Q4 2020

Feb 10, 2021

SELL
$45.3 - $51.62 $1.58 Million - $1.8 Million
-34,790 Reduced 32.76%
71,410 $3.47 Million
Q3 2020

Nov 12, 2020

SELL
$49.47 - $53.77 $1.29 Million - $1.4 Million
-26,110 Reduced 19.73%
106,200 $5.33 Million
Q2 2020

Aug 13, 2020

SELL
$42.91 - $52.5 $372,802 - $456,120
-8,688 Reduced 6.16%
132,310 $7.05 Million
Q1 2020

May 13, 2020

BUY
$38.02 - $51.66 $9,733 - $13,224
256 Added 0.18%
140,998 $6.16 Million
Q4 2019

Feb 12, 2020

SELL
$44.25 - $50.86 $3.15 Million - $3.62 Million
-71,147 Reduced 33.58%
140,742 $7.07 Million
Q3 2019

Nov 14, 2019

SELL
$40.34 - $46.64 $1.12 Million - $1.3 Million
-27,807 Reduced 11.6%
211,889 $9.77 Million
Q2 2019

Aug 14, 2019

SELL
$40.43 - $44.3 $788,142 - $863,584
-19,494 Reduced 7.52%
239,696 $10.4 Million
Q1 2019

May 14, 2019

SELL
$40.83 - $45.43 $2.39 Million - $2.66 Million
-58,540 Reduced 18.42%
259,190 $11.5 Million
Q4 2018

Feb 12, 2019

SELL
$41.48 - $45.59 $289,530 - $318,218
-6,980 Reduced 2.15%
317,730 $13.8 Million
Q3 2018

Nov 13, 2018

SELL
$40.0 - $44.84 $96 Million - $108 Million
-2,400,088 Reduced 88.08%
324,710 $14.5 Million
Q2 2018

Aug 14, 2018

SELL
$37.63 - $41.22 $681 Million - $746 Million
-18,107,782 Reduced 86.92%
2,724,798 $109 Million
Q1 2018

May 10, 2018

SELL
$38.98 - $45.76 $280,032 - $328,739
-7,184 Reduced 0.03%
20,832,580 $835 Million
Q4 2017

Feb 14, 2018

SELL
$42.86 - $50.61 $1.88 Million - $2.22 Million
-43,963 Reduced 0.21%
20,839,764 $896 Million
Q3 2017

Nov 13, 2017

BUY
$47.04 - $50.34 $982 Million - $1.05 Billion
20,883,727
20,883,727 $1.04 Billion

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.